iqpc corporate - all iqpc exchange venues are carefully selected to maximize the value of the...

8
Developed by www.clinicaltrials-exchange.com DELEGATE BROCHURE September 21-23, 2014 IQPC Exchange @IQPCNAExchange #CTI2014 IQPC Exchange IQPC Exchange

Upload: others

Post on 16-Oct-2020

4 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: IQPC Corporate - All IQPC Exchange venues are carefully selected to maximize the value of the Exchange to our participants. We choose venues that We choose venues that encourage high-level

Developed by

www.clinicaltrials-exchange.com

DELEGATE BROCHURE

September 21-23, 2014

IQPC Exchange@IQPCNAExchange

#CTI2014IQPC Exchange IQPC Exchange

Page 2: IQPC Corporate - All IQPC Exchange venues are carefully selected to maximize the value of the Exchange to our participants. We choose venues that We choose venues that encourage high-level

www.clinicaltrials-exchange.com | 800-398-1966 | [email protected]

Sept. 21-23, 2014

Welcome to the Clinical Trials & Innovation ExchangeThe Clinical Trials industry is extremely important in order for medicine to advance and seek treatment for patients in the future. Without these trials, drugs or medical devices would not mature and eventually find a cure for most medical conditions. Effective clinical trials have enabled new ways to prevent, detect, or treat disease and improve the quality of life of many people with chronic illnesses.

The Clinical Trials and Innovation Exchange is a part of a series of events focused on the pharmaceutical industry that will serve as the hub for clinical trial executives to meet, share ideas, benchmark and discuss solutions to real world problems. It will offer cutting-edge, interactive learning opportunities for pre-qualified practitioners to gain actionable insights and continue to improve the clinical trial process.

This exchange is designed for senior clinical and research executives who are responsible for leading the execution of sound clinical trials within the established costs, quality and time constraints. They are also responsible for driving operational excellence and building collaborative relationships with all stakeholders involved.

Being at the forefront of drug development and being innovative during the process are important issues that are on clinical trial executives’ minds. Executives working within clinical trials have the opportunity to improve ways to productively produce studies that will be successful and meet important milestones. As clinical trials continue to be an essential part of developing medical treatments, executives in this field are pressed to find innovative solutions to recruit patients, meet regulations and use the appropriate technology to complete trials in a timely manner and avoid exceeding the designated budget.

This is accomplished, in part, by:• Developing patent engagement and partnerships• Understanding and capitalizing on new technologies and solutions• Being at the forefront of an industry and discovering innovative ways of

conducting trials

Contact us today to find out how you can join this dynamic executive level affair. I look forward to seeing you in September at the Exchange.

Warmest regards,

Cynthia ColónProgram DirectorIQPC Exchange

TOP REASONS TO ATTENDUnique invitation-only event which will only SVPs, VPs, and Senior Directors of Clinical Operations and Clinical Trial Management from leading and innovative pharmaceutical and biotech companies.

• Unsurpassed formal and informal networking opportunities to share and exchange ideas and concepts.

• Benchmark your current strategies and initiatives with other leading companies in our exclusive BrainWeave® discussions.

• Meet the leading solution providers relevant to your business needs in private, prescheduled, one-on-one meetings.

• A wide range of conference and discussion sessions led by peer level presenters sharing case studies, best practices, and unique updates that are most relevant to your current priorities.

• Maximize your time out of office by customizing your own itinerary. Select the conference sessions, BrainWeave® discussions, and business meetings that match your initiatives and current business needs ensuring you have full control of your time at the Exchange.

Page 3: IQPC Corporate - All IQPC Exchange venues are carefully selected to maximize the value of the Exchange to our participants. We choose venues that We choose venues that encourage high-level

www.clinicaltrials-exchange.com | 800-398-1966 | [email protected]

Sept. 21-23, 2014

Leading Case Studies, Discussions & Debates Led By:

Shirley L. Paddock Chief Operations Officer Eli Lilly and Company, Chorus

Eugene Patin Head of US Clinical Operations Novartis Pharmaceuticals

Patrick Nealon Vice President of Clinical Operations, Oncology Takeda Pharmaceuticals

Christine Pierre President Society for Clinical Research Sites

Mollie Shields President and CEO SAFE-BioPharma Association

Steven Sweeney Head of Clinical Development Operations Arteaus Therapeutics

Raj Bandaru Head of Informatics Science, Clinical Operations Strategy AstraZeneca Pharmaceuticals

Ian Lauf US Head, Global Clinical Outsourcing & Alliance Management Eisai Pharmaceuticals

• Improving Patient Recruitment through Education • Hiring the Right External Resources to Support Clinical Research Trials

• Establishing Mobile as Integral Part of the Clinical Trials Process • Leveraging Data and Technology to Improve the Process of Clinical Research Trials • Keeping Up with Technology to Improve the Clinical Trials Experience • Optimizing and Controlling Budgets During a Study • Steering Clinical Research in Emerging Markets • Meeting Ethical Guidelines During Patient Enrollment in the Digital Era

Key Topics to be Addressed Include:

Page 4: IQPC Corporate - All IQPC Exchange venues are carefully selected to maximize the value of the Exchange to our participants. We choose venues that We choose venues that encourage high-level

www.clinicaltrials-exchange.com | 800-398-1966 | [email protected]

Sept. 21-23, 2014

CONFERENCE SESSIONS

The Clinical Trials & Innovation Exchange offers a variety of unique learning styles and sessions, which you can select from to build a customized itinerary that reflects your current initiatives, priorities, and future strategic objectives.

MORE VALUE FOR YOUR TIME OUT OF THE OFFICE

The highly crafted conference sessions reflect the strategic issues that senior clinical trial executives have identified as priorities during our lengthy research process. You will choose from a selection of plenary and concurrent sessions covering a myriad of issues that will create the foundation of your agenda. Session formats include: Co-presented Case Studies, Panel Discussions, Case Reviews, Roundtable Discussions and Interactive Debates.

• An integral part of your agenda is the one-on-one business meetings with leading solution providers. When you register for the Clinical Trials & Innovation Exchange, you will be asked to identify the solutions and services you are currently considering, so we can invite leading experts to the Exchange who will fit your business needs.

• Prior to the Exchange, you will be able to assess the solution providers who will be attending and select 6-8 who offer products and services that match your initiatives and priorities.

• Your selections are then incorporated into your customized agenda. These private thirty minute one-on-one meetings give you the opportunity to hear from leading specialists, whose industry knowledge and experience enable them to make a valuable contribution to the requirements of your business. They offer objective, flexible, and relevant strategies for success. This unique aspect of the Clinical Trials & Innovation Exchange serves to simplify the process for sourcing new solutions, enable you to discover strategies that are working for others and offer you early previews of emerging technologies.

ONE-ON-ONE BUSINESS MEETINGS

Our signature BrainWeave® sessions encourage discussion, debate and learning in an unscripted and informal setting. You can choose to participate in these interactive roundtable style sessions on topics which are top of mind issues. You will be able to select from four possible BrainWeave® topics which will be incorporated into your personal itinerary. These sixty minute discussions will be moderated to ensure that the discussions stay on-course and deliver maximum benefit to you. Ask questions, share experiences and ideas and find the right answers to your immediate concerns.

BRAINWEAVE® DISCUSSIONS

• Hardware, Software & Technology Solutions• e-Clinical• Content Management• Technology and Analytics• Patient Experience (Recruitment, Enrollment)• Core Labs and Services, Clinical Development Support

• CROs (Contract Research Organization), Consulting• Financial Management• Marketing Communications

/Strategic Planning/Branding/Digital• Regulatory Compliance• Security and Safety

SOLUTION PROVIDERS

Solution Providers are invited based on the requirements of attending delegates and specialize in the following areas:

Page 5: IQPC Corporate - All IQPC Exchange venues are carefully selected to maximize the value of the Exchange to our participants. We choose venues that We choose venues that encourage high-level

www.clinicaltrials-exchange.com | 800-398-1966 | [email protected]

Sept. 21-23, 2014

VENUE

Some of our past attendees include:

All IQPC Exchange venues are carefully selected to maximize the value of the Exchange to our participants. We choose venues that encourage high-level thinking in a relaxed atmosphere to ensure you get the most out of your time away from the office.

We are currently sourcing the venue for Clinical Trials & Innovation Exchange. Stay tuned for more information.

WHO YOU WILL MEET AT THE EXCHANGETo ensure the Clinical Trials & Innovation Exchange offers the highest degree of relevancy for attendees, only senior executives responsible for providing strategic leadership and guidance within their corporations are invited.

This exclusive format allows you to connect with those peers whose insights you respect most – through exceptional networking, business meetings, and strategic information sessions.

Clinical Trial and Innovation Exchange Delegates will include:• ChiefMedicalOfficers• SVP/VP/GlobalHead/Directorof: o Clinical Operations o Clinical Innovation o Clinical Trials Management & Affairs

Page 6: IQPC Corporate - All IQPC Exchange venues are carefully selected to maximize the value of the Exchange to our participants. We choose venues that We choose venues that encourage high-level

www.clinicaltrials-exchange.com | 800-398-1966 | [email protected]

Sept. 21-23, 2014

12:00 – 1:30 Registration

1:30 – 1: 45 Sponsor Orientation & Delegate Orientation

1:45 – 2:15 ICE BREAKER

2:15 - 2:25 Chairperson’s Opening Remarks

2:30 – 3:15 Opening Keynote AddressLeveraging Data and Technology to Improve the Process of Clinical Research Trials

3:15 – 4:00 Improving Patient Recruitment through Education 3:15 – 3:45 Business Meetings 1

4:00 – 4:15 Networking Break and Refreshments

4:15 – 5:00 Developing Innovative Clinical Trial Ideas and Bringing them Mainstream Eugene Patin Head of US Clinical Operations Novartis Pharmaceuticals

4:15 – 4:45 Business Meetings 2

5:00 – 5:45 Establishing Mobile as Integral Part of the Clinical Trials Process

Mollie Shields Uehling President& CEO SAFE-BioPharma Association

5:00 – 5:30 Business Meetings 3

5:50 – 6:50 BrainWeave A BrainWeave BLeveraging Cloud-based Solutions to Manage Clinical Trial Operations

Working with the FDA to Execute a Successful Study

6:50 – 7:20 Networking Drinks Reception

7:20 – 9:00 Networking Dinner

AGENDA Sunday, September 21, 2014DAY ONE

Page 7: IQPC Corporate - All IQPC Exchange venues are carefully selected to maximize the value of the Exchange to our participants. We choose venues that We choose venues that encourage high-level

www.clinicaltrials-exchange.com | 800-398-1966 | [email protected]

Sept. 21-23, 2014

8:00 – 9:00 Networking Breakfast

9:00 – 9:10 Chairperson’s Recap

9:10 – 10:10 Interactive Roundtables Interactive RoundtablesEmerging Technology- Which Technological Trends will arise to Improve the Clinical Trial Process?

Marketing - Developing Effective Marketing Strategies to Promote Clinical Trials

Optimizing the CRO’s Support During a Clinical Trial

Show & Tell- Which solutions have shown you the best results and ROI?

Future of e-Clinical- How does e-Clinical fit into daily use?

Using Modern Devices to Reach Patients and Spark Participation Interest

10:10 – 10:55 Hiring the Right External Resources to Support Clinical Research Trials

Christine Pierre, President Society for Clinical Research Sites

10:10 – 10:40 Business Meetings 4

10:55 – 11:10 Networking Break and Refreshments

11:55 – 12:55 Enhancing Operations to Improve Clinical Trial Initiatives

Patrick Nealon Vice President of Clinical Operations, Oncology, Takeda Pharmaceuticals

11:55 – 12:25 Business Meetings 5

12:55 -1:55 Networking Lunch

1:55 – 2:55 BrainWeave C BrainWeave DBuilding Risk Management into a Clinical Trial Meeting Regulations and Compliance with Proper Solutions

2:55 – 3:40 Stimulating Innovation within Big Pharma: A Ten year retrospective on the Lilly Chorus Experience

Shirley L. Paddock, Chief Operations Officer, Eli Lilly & Company, Chorus

2:55 – 3:25 Business Meetings 6

3:45 – 4:30 MasterClass A MasterClass BImplementing Robust Security Solutions to Protect Patient Data Optimizing Clinical Trial Management to Improve Performance

4:30 - 6:30 Business Meetings Business Meetings

4:30 – 5:00 Business Meetings 7 5:30 – 6:00 Business Meetings 9

5:00 – 5:30 Business Meeting 8 6:00 – 6:30 Business Meeting 10

6:30- 7:00 Networking Drinks

7:00 – 9:00 Networking Dinner

AGENDA Monday, September 22, 2014DAY TWO

Page 8: IQPC Corporate - All IQPC Exchange venues are carefully selected to maximize the value of the Exchange to our participants. We choose venues that We choose venues that encourage high-level

www.clinicaltrials-exchange.com | 800-398-1966 | [email protected]

Sept. 21-23, 2014

8:00 – 9:00 Networking Breakfast

9:00 – 9:10 Chairperson’s Recap

9:10 – 9:55 Using Data and Technology to Improve Studies

Raj Bandaru, Head of Informatics Science, Clinical Operations AztraZeneca Pharmaceuticals

9:10 – 9:40 Business Meetings 11

10:00 – 10:40 MasterClass C MasterClass DMaximizing Clinical Data Management & Statistics for Better Product Development

Implementing eTMP to Improve Clinical Research

10:40 – 10:55 Networking Break and Refreshments

10:55 – 11:40 Optimizing and Controlling Budgets During a Study

Ian Lauf, US Head, Global Clinical Outsourcing & Alliance Management Eisai Pharmaceuticals

10:55 – 11:20 Business Meetings 12

11:45 – 12:45 BrainWeave E BrainWeave FLeveraging Business Analytics to Predict Future Trends Improving Patient Recruitment to Meet Milestones

12:45 – 1:30 Improving Clinical Trial Relationships

Steven Sweeney, Head of Clinical Development Operations Arteaus Therapeutics

12:45 – 1:15 Business Meetings 13

1:30 End of Exchange

AGENDA Tuesday, September 23, 2014 DAY THREE

The Clinical Trials & Innovation Exchange doesn’t just provide you with a once-a-year opportunity to meet with your peers. Through a range of online channels we’re delighted to be able to facilitate all year round learning and networking for theClinical Trials & In-novation Exchange community. Stay connected through Twitter, YouTube, LinkedIn, Facebook and our online Resource Library, and get the latest new, event updates, exclusive videos, whitepapers and more!

IQPC Exchange@IQPCNAExchange

#CTI2014IQPC Exchange IQPC Exchange

KEEP CONNECTED WITH US: